These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28399801)

  • 1. Is the impact of childhood influenza vaccination less than expected: a transmission modelling study.
    Weidemann F; Remschmidt C; Buda S; Buchholz U; Ultsch B; Wichmann O
    BMC Infect Dis; 2017 Apr; 17(1):258. PubMed ID: 28399801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model of influenza infection and vaccination in children aged under 5 years in Beijing, China.
    Zhang Y; Muscatello DJ; Cao Z; Chughtai AA; Costantino V; Zhang D; Yang P; Wang Q; MacIntyre CR
    Hum Vaccin Immunother; 2020 Jul; 16(7):1685-1690. PubMed ID: 31995439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of influenza-attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02-2014/15.
    An der Heiden M; Buchholz U
    Influenza Other Respir Viruses; 2017 Mar; 11(2):110-121. PubMed ID: 27754611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinating children against influenza increases variability in epidemic size.
    Backer JA; van Boven M; van der Hoek W; Wallinga J
    Epidemics; 2019 Mar; 26():95-103. PubMed ID: 30529023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
    Molnar D; Anastassopoulou A; Poulsen Nautrup B; Schmidt-Ott R; Eichner M; Schwehm M; Dos Santos G; Ultsch B; Bekkat-Berkani R; von Krempelhuber A; Van Vlaenderen I; Van Bellinghen LA
    Hum Vaccin Immunother; 2022 Nov; 18(5):2058304. PubMed ID: 35486410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach.
    Rajaram S; Wiecek W; Lawson R; Blak BT; Zhao Y; Hackett J; Brody R; Patel V; Amzal B
    PLoS One; 2017; 12(12):e0186739. PubMed ID: 29244811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign.
    Grijalva CG; Zhu Y; Simonsen L; Griffin MR
    Vaccine; 2010 Dec; 29(1):123-9. PubMed ID: 21050905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
    Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
    Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study.
    Rose MA; Damm O; Greiner W; Knuf M; Wutzler P; Liese JG; Krüger H; Wahn U; Schaberg T; Schwehm M; Kochmann TF; Eichner M
    BMC Infect Dis; 2014 Jan; 14():40. PubMed ID: 24450996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
    Lugnér AK; van Boven M; de Vries R; Postma MJ; Wallinga J
    BMJ; 2012 Jul; 345():e4445. PubMed ID: 22791791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler G; Riggs M; Griffith M; Fewlass C; Watts M; Hessel C; Cordova J; Glezen WP
    Vaccine; 2005 Feb; 23(13):1540-8. PubMed ID: 15694506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.
    King JC; Lichenstein R; Magder LS
    Vaccine; 2013 Jan; 31(5):839-44. PubMed ID: 23219798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness.
    Omer SB; Phadke VK; Bednarczyk RA; Chamberlain AT; Brosseau JL; Orenstein WA
    J Infect Dis; 2016 Apr; 213(8):1216-23. PubMed ID: 26516141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany.
    Eichner M; Schwehm M; Hain J; Uphoff H; Salzberger B; Knuf M; Schmidt-Ott R
    BMC Infect Dis; 2014 Jul; 14():365. PubMed ID: 24993051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States.
    Arinaminpathy N; Kim IK; Gargiullo P; Haber M; Foppa IM; Gambhir M; Bresee J
    Am J Epidemiol; 2017 Jul; 186(1):92-100. PubMed ID: 28369163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations.
    Schmidt-Ott R; Molnar D; Anastassopoulou A; Yanni E; Krumm C; Bekkat-Berkani R; Dos Santos G; Henneke P; Knuf M; Schwehm M; Eichner M
    Hum Vaccin Immunother; 2020 Apr; 16(4):836-845. PubMed ID: 31647348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines for preventing influenza in healthy adults.
    Demicheli V; Jefferson T; Ferroni E; Rivetti A; Di Pietrantonj C
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD001269. PubMed ID: 29388196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of live attenuated influenza vaccination programme for healthy children in Northern Ireland: A comparison of seven influenza seasons, 2010/11-2016/17.
    Gallagher N; Jessop L; Sartaj M; Johnston J
    Vaccine; 2018 Jan; 36(4):521-526. PubMed ID: 29275988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis.
    Sandmann FG; van Leeuwen E; Bernard-Stoecklin S; Casado I; Castilla J; Domegan L; Gherasim A; Hooiveld M; Kislaya I; Larrauri A; Levy-Bruhl D; Machado A; Marques DFP; Martínez-Baz I; Mazagatos C; McMenamin J; Meijer A; Murray JLK; Nunes B; O'Donnell J; Reynolds A; Thorrington D; Pebody R; Baguelin M
    Vaccine; 2022 Feb; 40(9):1306-1315. PubMed ID: 35109968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.